Freiburg, Germany

Anna Koprivova

This inventor holds 1 USPTO granted patent. Top assignee: Greenovation Biotech Gmbh. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Koprivova. Retrieved from https://idiyas.com/inventor/anna-koprivova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anna Koprivova

Introduction

Anna Koprivova is a notable inventor based in Freiburg, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of glycosylated proteins. Her work is characterized by a focus on bryophyte plants and their potential applications in biotechnology.

Latest Patents

Anna Koprivova holds a patent for her invention titled "Transformed bryophyte cell having disrupted endogenous alpha 1,3-fucosyl and beta 1,2-xylosyl transferase encoding nucleotide sequences for the production of heterologous glycosylated proteins." This patent involves bryophyte plants and bryophyte plant cells that comprise dysfunctional fucT and xylT genes, along with an introduced glycosyltransferase gene. The methods for the production of glycosylated proteins, vectors, and their uses are also covered in this patent. She has 1 patent to her name.

Career Highlights

Anna is currently employed at Greenovation Biotech GmbH, where she continues to advance her research and innovations. Her work at the company focuses on the application of her patented technologies in practical settings.

Collaborations

Anna collaborates with esteemed colleagues, including Ralf Reski and Eva Decker, who contribute to her research endeavors and help in the development of her innovative projects.

Conclusion

Anna Koprivova is a pioneering inventor whose work in biotechnology is paving the way for new advancements in the production of glycosylated proteins. Her contributions are significant and continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…